| Year |
Citation |
Score |
| 2013 |
Hu M, Lan W, Lam CW, Mak YT, Pang CP, Tomlinson B. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases. International Journal of Cardiology. 167: 762-7. PMID 22464486 DOI: 10.1016/J.Ijcard.2012.03.048 |
0.491 |
|
| 2001 |
Tomlinson B, Chan P, Lan W. How well tolerated are lipid-lowering drugs? Drugs & Aging. 18: 665-83. PMID 11599634 DOI: 10.2165/00002512-200118090-00003 |
0.411 |
|
| 2001 |
Tomlinson B, Lan W. Hypothyroidism and simvastatin. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. 7: 219-20. PMID 11514761 |
0.314 |
|
| 1998 |
Mok PH, Tomlinson B, Lan W, Sanderson JE, Woo KS. P094 Lipid abnormalities and their treatment in patients with acute myocardial infarction in Hong Kong Atherosclerosis. 136: S72. DOI: 10.1016/S0021-9150(97)84666-7 |
0.405 |
|
| 1998 |
Tomlinson B, Lan W, Mak Y, Chan Y, Mak TW-, Critchley JAJH, Maserei JRL, Pang C. F049 Familial hypercholesterolaemia in Hong Kong Atherosclerosis. 136. DOI: 10.1016/S0021-9150(97)84626-6 |
0.438 |
|
| 1998 |
Tomlinson B, Wong S, Lan W, Critchley JA, Mak TW, Lam CW, Woo KS, Sanderson JB. F038 Combination treatment with fluvastatin and gemfibrozil in resistant hyperlipidaemia Atherosclerosis. 136: S56. DOI: 10.1016/S0021-9150(97)84615-1 |
0.442 |
|
| 1998 |
Lan W, Tomlinson B, Chau Y, Say T, Lee KK, Critchley JA, Mak TW, Lam CW. F036 Response to bezafibrate in combined hyperlipidaemia Atherosclerosis. 136: S55. DOI: 10.1016/S0021-9150(97)84609-6 |
0.421 |
|
| 1997 |
Tomlinson B, Wong S, Lan W, Critchley J, Mak T, Lam C, Woo K, Sanderson J. 1.P.217 Effects of fluvastatin alone and in combination with gemfibrozil on lipids and glucose tolerance in resistant hyperlipidaemia Atherosclerosis. 134: 62. DOI: 10.1016/S0021-9150(97)88396-7 |
0.401 |
|
| Show low-probability matches. |